These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Betidamino acid scan of the GnRH antagonist acyline. Jiang G; Miller C; Koerber SC; Porter J; Craig AG; Bhattacharjee S; Kraft P; Burris TP; Campen CA; Rivier CL; Rivier JE J Med Chem; 1997 Nov; 40(23):3739-48. PubMed ID: 9371239 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis). Weinbauer GF; Nieschlag E Andrologia; 1993; 25(3):141-7. PubMed ID: 8517553 [TBL] [Abstract][Full Text] [Related]
9. Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II. Samant MP; Gulyas J; Hong DJ; Croston G; Rivier C; Rivier J J Med Chem; 2005 Jul; 48(15):4851-60. PubMed ID: 16033265 [TBL] [Abstract][Full Text] [Related]
10. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. Rivier JE; Porter J; Rivier CL; Perrin M; Corrigan A; Hook WA; Siraganian RP; Vale WW J Med Chem; 1986 Oct; 29(10):1846-51. PubMed ID: 2428978 [TBL] [Abstract][Full Text] [Related]
11. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH. Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622 [TBL] [Abstract][Full Text] [Related]
12. Antiovulatory antagonists of LHRH related to antide. Flouret G; Arnold ZS; Majewski T; Petousis NH; Mahan K; Farooqui F; Blum KA; Konopinska D; Natarajan S; Crich D J Pept Sci; 1995; 1(2):89-108. PubMed ID: 9222987 [TBL] [Abstract][Full Text] [Related]
15. A 90-day subcutaneous toxicity and fertility study of a LHRH antagonist in rats. Sundaram K; Didolkar AK; Keizer-Zucker A; DeJesus W; Rivier J; Vale W; Bardin CW Fundam Appl Toxicol; 1990 May; 14(4):734-44. PubMed ID: 1694507 [TBL] [Abstract][Full Text] [Related]
16. Potent gonadotropin releasing hormone antagonists with low histamine-releasing activity. Nestor JJ; Tahilramani R; Ho TL; Goodpasture JC; Vickery BH; Ferrandon P J Med Chem; 1992 Oct; 35(21):3942-8. PubMed ID: 1279174 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and theoretical conformational studies of gonadotropin-releasing hormone analogs containing tetrahydroisoquinoline carboxylic acid. Koerber SC; Ibea M; Hagler AT; Rivier CL; Rivier JE Biochem Biophys Res Commun; 1992 Sep; 187(2):1035-41. PubMed ID: 1530601 [TBL] [Abstract][Full Text] [Related]
19. Antide and related antagonists of luteinizing hormone release with long action and oral activity. Ljungqvist A; Feng DM; Hook W; Shen ZX; Bowers C; Folkers K Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8236-40. PubMed ID: 2460863 [TBL] [Abstract][Full Text] [Related]
20. Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7. Flouret G; Mahan K; Majewski T J Med Chem; 1992 Feb; 35(4):636-40. PubMed ID: 1371810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]